Clinical Trials & Results
Find a Trial or Results of a Completed Trial
Showing 20 of 230 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Clear Filters
Study ID: 116B8 | 2009-010562-31
- Condition(s):
- Stable Renal Transplant Recipients
- Status:
- Terminated
- Requirements:
- 18 Years and older
- Interventions:
- Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)
Study ID: 9006
- Condition(s):
- Relapse-Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 40 mg
Study ID: 9013
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Betaseron | Drug: Rebif
Study ID: ABM-AS-307
- Condition(s):
- Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis
- Status:
- Completed
- Requirements:
- 4 Years and older
- Interventions:
- Drug: Albuterol
Study ID: ABS-AS-101
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 18 Years to 45 Years
- Interventions:
- Drug: Albuterol dry powder inhaler | Drug: Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
Study ID: ABS-AS-102
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 4 Years to 11 Years
- Interventions:
- Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA
Study ID: ABS-AS-201
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler
Study ID: ABS-AS-202
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 4 Years to 11 Years
- Interventions:
- Drug: Albuterol Spiromax | Drug: ProAir HFA | Drug: Placebo
Study ID: ABS-AS-30064
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Albuterol Sulfate
Study ID: ABS-AS-301
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Placebo MDPI | Drug: Albuterol MDPI
Study ID: ABS-AS-302
- Condition(s):
- Exercise-Induced Bronchoconstriction (EIB)
- Status:
- Completed
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: Albuterol Spiromax | Drug: Placebo Spiromax
Study ID: ABS-AS-303
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 4 Years to 11 Years
- Interventions:
- Drug: Albuterol MDPI | Drug: Placebo | Drug: ProAir HFA inhaler
Study ID: ABS-AS-304
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Placebo MDPI | Drug: Albuterol MDPI
Study ID: ABS-AS-306
- Condition(s):
- Asthma
- Status:
- Terminated
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Placebo Spiromax | Drug: Albuterol Spiromax
Study ID: ABS-AS-307
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Placebo MDPI | Drug: Albuterol MDPI
Study ID: ABS-AS-308
- Condition(s):
- Asthma | Chronic Obstructive Pulmonary Disease (COPD)
- Status:
- Completed
- Requirements:
- 4 Years and older
- Interventions:
- Drug: Albuterol Spiromaxֲ®
Study ID: ABS-AS-40138
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 13 Years and older
- Interventions:
- Drug: Albuterol eMDPI DS | Drug: albuterol
Study ID: ABS-COPD-30065
- Condition(s):
- Chronic Obstructive Pulmonary Disease
- Status:
- Completed
- Requirements:
- 40 Years and older
- Interventions:
- Drug: Albuterol sulfate (ABS)
Study ID: ACR16 C008
- Condition(s):
- Huntington's Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Drug: ACR16 | Drug: Placebo
Study ID: ACR16 C009
- Condition(s):
- Huntington Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Drug: ACR16 10 mg | Drug: ACR16 22.5 mg | Drug: ACR16 45 mg | Other: Placebo
